Liangchang Li

888 total citations
38 papers, 584 citations indexed

About

Liangchang Li is a scholar working on Immunology, Molecular Biology and Physiology. According to data from OpenAlex, Liangchang Li has authored 38 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 16 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in Liangchang Li's work include Asthma and respiratory diseases (7 papers), Mast cells and histamine (6 papers) and Dermatology and Skin Diseases (4 papers). Liangchang Li is often cited by papers focused on Asthma and respiratory diseases (7 papers), Mast cells and histamine (6 papers) and Dermatology and Skin Diseases (4 papers). Liangchang Li collaborates with scholars based in China, South Korea and Japan. Liangchang Li's co-authors include Guanghai Yan, Jingzhi Jiang, Li Li, Chang Xu, Yilan Song, Hongmei Piao, Mingyu Zheng, Chongyang Wang, Yun Ho Choi and Guangyu Jin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Agricultural and Food Chemistry and Scientific Reports.

In The Last Decade

Liangchang Li

36 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liangchang Li China 15 265 164 120 67 62 38 584
Jingzhi Jiang China 16 262 1.0× 162 1.0× 124 1.0× 61 0.9× 59 1.0× 30 587
Fangzhou Teng China 14 215 0.8× 127 0.8× 151 1.3× 45 0.7× 155 2.5× 22 557
Qinggao Zhang China 20 404 1.5× 243 1.5× 99 0.8× 30 0.4× 52 0.8× 51 919
Yu Tao China 19 376 1.4× 122 0.7× 97 0.8× 54 0.8× 27 0.4× 28 786
La Yi China 13 201 0.8× 106 0.6× 124 1.0× 37 0.6× 144 2.3× 20 496
Yonghae Son South Korea 14 294 1.1× 202 1.2× 69 0.6× 25 0.4× 25 0.4× 40 601
Mohamed M. Al-Harbi Saudi Arabia 9 128 0.5× 108 0.7× 106 0.9× 18 0.3× 52 0.8× 10 476
Keun‐Ai Moon South Korea 14 225 0.8× 169 1.0× 177 1.5× 26 0.4× 135 2.2× 16 605
Laure Favot France 18 381 1.4× 226 1.4× 104 0.9× 47 0.7× 27 0.4× 33 789

Countries citing papers authored by Liangchang Li

Since Specialization
Citations

This map shows the geographic impact of Liangchang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangchang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangchang Li more than expected).

Fields of papers citing papers by Liangchang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangchang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangchang Li. The network helps show where Liangchang Li may publish in the future.

Co-authorship network of co-authors of Liangchang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Liangchang Li. A scholar is included among the top collaborators of Liangchang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangchang Li. Liangchang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Dan & Liangchang Li. (2025). Obtusifolin ameliorates dry eye model in rats by reducing inflammation and blocking MAPK/NF-κB pathways. International Journal of Ophthalmology. 18(8). 1426–1432.
2.
Wang, Chongyang, Ning Ding, Liangchang Li, et al.. (2025). Eupalinolide B targets DEK and PANoptosis through E3 ubiquitin ligases RNF149 and RNF170 to negatively regulate asthma. Phytomedicine. 141. 156657–156657. 1 indexed citations
3.
Ding, Ning, et al.. (2025). Artemetin targets the ABCG2/RAB7A axis to inhibit mitochondrial dysfunction in asthma. Phytomedicine. 140. 156600–156600. 4 indexed citations
5.
Li, Liangchang, Lingling Dai, Yan Li, et al.. (2024). Mechanism of action of miR-15b-5p in alleviating asthma airway remodeling through the HMGB1/TLR4/IL-33 signaling axis. International Immunopharmacology. 145. 113753–113753. 1 indexed citations
6.
Dai, Lingling, Jianing Yang, Jiangang Wang, et al.. (2024). Deficiency of DEK proto‐oncogene alleviates allergic rhinitis by inhibiting RhoA /Ezrin‐mediated mitochondrial fission. SHILAP Revista de lepidopterología. 8(11). 1947–1959.
7.
Song, Yilan, Xingmei Wang, Xinrui Li, et al.. (2023). JTE-013 Alleviates Pulmonary Fibrosis by Affecting the RhoA/YAP Pathway and Mitochondrial Fusion/Fission. Pharmaceuticals. 16(10). 1444–1444. 3 indexed citations
8.
Zuo, Dongmei, et al.. (2022). COVID-19 infection with keratitis as the first clinical manifestation. International Journal of Ophthalmology. 15(9). 1544–1548. 7 indexed citations
9.
Song, Yilan, et al.. (2022). MicroRNA-182-5p Attenuates Asthmatic Airway Inflammation by Targeting NOX4. Frontiers in Immunology. 13. 853848–853848. 17 indexed citations
10.
Zhang, Yalin, Yilan Song, Chongyang Wang, et al.. (2022). Panax notoginseng saponin R1 attenuates allergic rhinitis through AMPK/Drp1 mediated mitochondrial fission. Biochemical Pharmacology. 202. 115106–115106. 21 indexed citations
11.
Jiang, Jingzhi, Chongyang Wang, Shan Jin, et al.. (2021). Glaucocalyxin A Attenuates Allergic Responses by Inhibiting Mast Cell Degranulation through p38MAPK/NrF2/HO-1 and HMGB1/TLR4/NF-κB Signaling Pathways. Evidence-based Complementary and Alternative Medicine. 2021. 1–11. 10 indexed citations
12.
Xu, Chang, Liangchang Li, Chongyang Wang, et al.. (2021). Effects of G-Rh2 on mast cell-mediated anaphylaxis via AKT-Nrf2/NF-κB and MAPK-Nrf2/NF-κB pathways. Journal of Ginseng Research. 46(4). 550–560. 27 indexed citations
13.
Song, Yilan, Jingzhi Jiang, Li Li, et al.. (2020). DEK‐targeting aptamer DTA‐64 attenuates bronchial EMT‐mediated airway remodelling by suppressing TGF‐β1/Smad, MAPK and PI3K signalling pathway in asthma. Journal of Cellular and Molecular Medicine. 24(23). 13739–13750. 46 indexed citations
14.
Choi, Yun Ho, Mingyu Zheng, Jingzhi Jiang, et al.. (2020). Imperatorin alleviates ROS-mediated airway remodeling by targeting the Nrf2/HO-1 signaling pathway. Bioscience Biotechnology and Biochemistry. 84(5). 898–910. 23 indexed citations
15.
17.
Jin, Guangyu, Hongmei Li, Jingzhi Jiang, et al.. (2019). Imperatorin Suppresses Anaphylactic Reaction and IgE-Mediated Allergic Responses by Inhibiting Multiple Steps of FceRI Signaling in Mast Cells: IMP Alleviates Allergic Responses in PCA. BioMed Research International. 2019. 1–12. 21 indexed citations
18.
Li, Liangchang, et al.. (2016). Sesamin attenuates allergic airway inflammation through the suppression of nuclear factor-kappa B activation. Experimental and Therapeutic Medicine. 12(6). 4175–4181. 16 indexed citations
19.
Li, Liangchang, Guangyu Jin, Jingzhi Jiang, et al.. (2016). Cornuside inhibits mast cell-mediated allergic response by down-regulating MAPK and NF-κB signaling pathways. Biochemical and Biophysical Research Communications. 473(2). 408–414. 33 indexed citations
20.
Lee, Kyung Sun, Hee Sun Park, Seoung Ju Park, et al.. (2006). An antioxidant modulates expression of receptor activator of NF-κB in asthma. Experimental & Molecular Medicine. 38(3). 217–229. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026